SCHEMBL8970587

SCHEMBL8970587

CC(CC(=O)O)[Si](C)(C)C

nearest known ligand 0.52

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SLC22A6 Q4U2R8 1/20 0.41
TDP1 Q9NUW8 2/20 0.39
CACNA2D1 P54289 2/20 0.38
CACNB3 P54284 1/20 0.38
CACNA1C Q13936 1/20 0.38
PGR P06401 1/20 0.38
ADRA1A P35348 1/20 0.38
HTR2B P41595 1/20 0.38
CACNA2D2 Q9NY47 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
MAPT P10636 2/20 0.36
ALDH1A1 P00352 2/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
GABRR1 P24046 2/20 0.35
LMNA P02545 1/20 0.35
HTT P42858 1/20 0.34
FFAR3 O14843 1/20 0.33
TSHR P16473 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL9067525 0.77 SLC22A6 (0.36) SLC22A6TDP1CACNA2D1CACNB3CACNA1C
SCHEMBL5057193 0.76 SLC22A6 (0.39) SLC22A6TDP1CACNA2D1CACNB3CACNA1C
SCHEMBL21819661 0.75 SLC22A6 (0.35) SLC22A6TDP1CACNA2D1CACNB3CACNA1C
SCHEMBL6418946 0.75 TET2 (0.46)
SCHEMBL1756480 0.75 SLC22A6 (0.35) SLC22A6TDP1CACNA2D1CACNB3CACNA1C
SCHEMBL4319153 0.70 TDP1 (0.43) SLC22A6TDP1ADRA1ASMN1; SMN2MAPT
SCHEMBL5003457 0.70 TDP1 (0.43) SLC22A6TDP1ADRA1ASMN1; SMN2MAPT
SCHEMBL304303 0.69 SLC22A6 (0.50) SLC22A6TDP1CACNA2D1CACNB3CACNA1C
SCHEMBL258152 0.69 SLC22A6 (0.50) SLC22A6TDP1CACNA2D1CACNB3CACNA1C
SCHEMBL5077944 0.69 SLC22A6 (0.50) SLC22A6TDP1CACNA2D1CACNB3CACNA1C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5536732-A REDUCING INFECTIOUSNESS OF HIV MERRELL PHARMACEUTICALS INC. (US) 1996-07-16 US disclosed
US-5252587-A Viricides, aids therapy, antidiabetic agent MERRELL DOW PHARMACEUTICALS, INC. (US) 1993-10-12 US disclosed
EP-0454580-A2 Novel nojirimycin derivatives MERRELL DOW PHARMACEUTICALS INC. (US) 1991-10-30 EP disclosed
EP-0453692-A1 Novel nojirimycin derivatives MERRELL DOW PHARMACEUTICALS INC. (US) 1991-10-30 EP disclosed
EP-0008130-B1 ORGANOSILICON COUMPOUNDS FOR THE TREATMENT OF HYPERTENSION AND TUMORS Shin-Etsu Chemical Co., Ltd. (JP) 1982-12-15 EP disclosed
US-4336251-A Medicaments containing an organosilicon compound SHIN-ETSU CHEMICAL CO., LTD. (JP) 1982-06-22 US disclosed
US-4336251-A Medicaments containing an organosilicon compound SHIN-ETSU CHEMICAL CO., LTD. (JP) 1982-06-22 US disclosed
EP-0008130-A1 Organosilicon coumpounds for the treatment of hypertension and tumors Shin-Etsu Chemical Co., Ltd. (JP) 1980-02-20 EP disclosed
EP-0008130-A1 Organosilicon coumpounds for the treatment of hypertension and tumors Shin-Etsu Chemical Co., Ltd. (JP) 1980-02-20 EP disclosed